new_0222_0554|ITOS|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0554|ITOS|Long Name|1|1|ITeos Therapeutics Inc Total Current Assets (Quarterly) (USD)|ITeos Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|ITeos Therapeutics Inc Inventories (Quarterly) (USD)|ITeos Therapeutics Inc Net PP&E (Quarterly) (USD)|ITeos Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|ITeos Therapeutics Inc Total Liabilities (Quarterly) (USD)|ITeos Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|ITeos Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|ITeos Therapeutics Inc Total Deposits (Quarterly) (USD)|ITeos Therapeutics Inc Book Value (Quarterly) (USD)|ITeos Therapeutics Inc Retained Earnings (Quarterly) (USD)|ITeos Therapeutics Inc Treasury Stock (Quarterly) (USD)|ITeos Therapeutics Inc EV to Revenues|ITeos Therapeutics Inc EV to Earnings|ITeos Therapeutics Inc EV to Free Cash Flow|ITeos Therapeutics Inc EV to Assets (Quarterly)|ITeos Therapeutics Inc PS Ratio|ITeos Therapeutics Inc PE Ratio|ITeos Therapeutics Inc Price to Book Value|ITeos Therapeutics Inc PEG Ratio|ITeos Therapeutics Inc Debt to Equity Ratio|ITeos Therapeutics Inc Dividend Yield|ITeos Therapeutics Inc Shareholder Yield (TTM)|ITeos Therapeutics Inc Percent of Shares Outstanding Short|ITeos Therapeutics Inc Total Receivables (Quarterly) (USD)|ITeos Therapeutics Inc Total Payables (Quarterly) (USD)|ITeos Therapeutics Inc Total Capital Stock (Quarterly) (USD)|ITeos Therapeutics Inc Return on Invested Capital|ITeos Therapeutics Inc Quality Ratio Score|ITeos Therapeutics Inc Momentum Score|ITeos Therapeutics Inc Beta (1Y)|ITeos Therapeutics Inc Sustainable Growth Rate (TTM)|ITeos Therapeutics Inc Institutional Investor Ownership Percentage|ITeos Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|ITeos Therapeutics Inc Total Employees (Annual)|ITeos Therapeutics Inc EPS Diluted (Quarterly) (USD)|ITeos Therapeutics Inc SG&A Expense (Quarterly) (USD)|ITeos Therapeutics Inc Shares Outstanding|ITeos Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|ITeos Therapeutics Inc Ordinary Shares Number (Quarterly)|ITeos Therapeutics Inc Payout Ratio|ITeos Therapeutics Inc Quick Ratio (Quarterly)|ITeos Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|ITeos Therapeutics Inc Stock Buybacks (Quarterly) (USD)|ITeos Therapeutics Inc Effective Tax Rate (TTM)|ITeos Therapeutics Inc Return on Equity|ITeos Therapeutics Inc Net Income (TTM) (USD)|ITeos Therapeutics Inc Revenue (TTM) (USD)|ITeos Therapeutics Inc Dividend Per Share (Quarterly) (USD)|ITeos Therapeutics Inc Revenue (Quarterly) (USD)|ITeos Therapeutics Inc Gross Profit (Quarterly) (USD)|ITeos Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|ITeos Therapeutics Inc Net Income (Quarterly) (USD)|ITeos Therapeutics Inc Net Interest Income (Quarterly) (USD)|ITeos Therapeutics Inc Price (USD)|ITeos Therapeutics Inc Total Return Price (USD)|ITeos Therapeutics Inc Enterprise Value (USD)|ITeos Therapeutics Inc 30-Day Average Daily Volume|ITeos Therapeutics Inc 1 Year Price Returns (Daily)|ITeos Therapeutics Inc Short Interest|ITeos Therapeutics Inc PE Ratio (Forward)|ITeos Therapeutics Inc PE Ratio (Forward 1y)|ITeos Therapeutics Inc PS Ratio (Forward)|ITeos Therapeutics Inc PS Ratio (Forward 1y)|ITeos Therapeutics Inc Quarterly EPS Estimates (USD)|ITeos Therapeutics Inc Quarterly Revenue Estimates (USD)|ITeos Therapeutics Inc Quarterly EPS Surprise|ITeos Therapeutics Inc Quarterly Revenue Surprise|ITeos Therapeutics Inc Quarterly Actual EPS (USD)|ITeos Therapeutics Inc Quarterly Actual Revenue (USD)|ITeos Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|ITeos Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|ITeos Therapeutics Inc Price Target (USD)|ITeos Therapeutics Inc Consensus Recommendation|ITeos Therapeutics Inc Price Target Num Estimates|ITeos Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|ITeos Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|ITeos Therapeutics Inc Research and Development Expense (Quarterly) (USD)|ITeos Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|ITeos Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|ITeos Therapeutics Inc Land and Improvements (Quarterly) (USD)|ITeos Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|ITeos Therapeutics Inc Other Properties (Quarterly) (USD)|ITeos Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0554|ITOS|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0554|ITOS||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0554|ITOS||5|5|91.2857142857|91.2857142857|0|91.2857142857|0|91.2857142857|91.2857142857|91.2857142857|0|91.2857142857|91.2857142857|0|0|0|1.44584382872|0|0|1.4387755102|1.44571428571|0|0|1.44584382872|0|15.25|91.2857142857|91.2857142857|91.2857142857|0|0|30.6|30.6666666667|0|30|91.4|94.4|91.4|91.4|35.4285714286|91.4|91.2857142857|0|0|91.4|91.375|0|0|91.2857142857|0|0|0|0|91.4|91.4|0|1.44584382872|1.44584382872|1.44584382872|1.44836956522|1.4275862069|15.25|1.44755244755|1.45019920319|1.44755244755|1.44755244755|91.4|91.4|91.4|92|91.4|91.4|24.1818181818|25.3333333333|18.3448275862|12.6666666667|18.3448275862|24.1818181818|26.6|91.4|91.4|0|0|0|91.2857142857|91.2857142857
new_0222_0554|ITOS||6|6|7|7|0|7|0|7|7|7|0|7|7|0|0|0|397|0|0|98|350|0|0|397|0|36|7|7|7|0|0|5|6|0|3|10|5|10|10|14|10|7|0|0|10|8|0|0|7|0|0|0|0|10|10|0|397|397|397|368|145|36|286|251|286|286|10|10|5|1|5|5|22|21|29|42|29|22|20|10|10|0|0|0|7|7
new_0222_0554|ITOS||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0554|ITOS|201903|201903|201903||||||||||||||||||||||||||||||||||9.9125||-0.5252|1.769||0||||-0.5252|||||||||-4.402|-4.402|||||||||||||||||||||||||4.351|0.149|||||
new_0222_0554|ITOS|201906|201906|201906||||||||||||||||||||||||||||||||||9.9125||-0.6836|2.093||0||||-0.5806|||||||||-5.697|-5.755|||||||||||||||||||||||||3.902|0.158|||||
new_0222_0554|ITOS|201909|201909|201909||||||||||||||||||||||||||||||||||9.9125||-0.8062|2.699||0||||-0.6982|0||||||||-6.892|-6.921|||||||||||||||||||||||||4.998|0.158|||||
new_0222_0554|ITOS|201912|201912|201912|26.076|19.868||1.336||66.832|13.196|53.636||-36.088|-35.865||||||||||||||5.329|1.174|0.001|||||||9.9125||-0.662|2.276||0|31.7485|||-0.5423|0|||-22.454|||||-5.344|-5.376|||||||||||||||||||||||||5.96|0.146||||2.3|0.346
new_0222_0554|ITOS|202003|202003|202003|149.271|147.732||1.244||14.518|9.973|4.545||139.452|-41.112||||||||||||||0.233|4.511|0.022|||||||31.7485||-0.2063|2.418||-0.332|31.7485|||-0.1653||||-23.299|||||-5.247|-5.247|||||||||||||||||||||||||5.825|0.121||||2.271|0.361
new_0222_0554|ITOS|202006|202006|202006|140.395|136.87||1.251||12.161|7.516|4.645||-47.922|-48.314||||||||||||||0.345|2.656|180.973|||||||31.7485|46|-0.3245|2.394|31.7485|0|31.7485|||-0.3245||||-24.746|||||-7.252|-7.202||||||||||||-0.4833|0|38.9757||-0.2949|0||||||||6.137|0.129||||2.326|0.445
new_0222_0554|ITOS|202007|202006|202006|||||||||||||||-31.7189|||||||0||5.5244||||||||||||||33.4348|||||||||||||||||19.68|19.68|702.0989|||1847084||||||||||||||||||||||||
new_0222_0554|ITOS|202008|202006|202006|||||||||||||||-47.9061|||||||0||1.0847||||||||||||||35.0448|||||||||||||||||29|29|1060.4012|||380120|||||||||||0|0|42.75|1.5|4|-1.8212|-2.0678|||||||
new_0222_0554|ITOS|202009|202009|202009|345.734|339.981||1.287||15.318|10.325|4.993||335.626|-58.994||||-19.5292||||2.5759|||0||2.0521|2.491|2.409|0.035|||||||24.3492|55|-0.48|4.799|35.0448|0|35.0448|||-0.48|-213.66|||-28.505|||||-10.688|-10.68||24.67|24.67|524.5742|209487.7333||719149|||||-0.287|0|-67.2241||-0.48|0|0|0|45|1.5|3|-1.5657|-1.5304|8.726|0.142||||2.427|0.48
new_0222_0554|ITOS|202010|202009|202009|||||||||||||||-17.0503||||2.3776|||0||0.9143||||||||||||||35.0448|||||||||||||||||22.77|22.77|457.9891|113309.8333||320425|||||||||||0|0|45|1.4|4|||||||||
new_0222_0554|ITOS|202011|202009|202009|||||||||||||||-22.2951||||2.7973|||0||1.0542|||||||||96.4924||||||||||||||||||||||26.79|26.79|598.8692|115012.8||369454|||||||||||0|0|43.6|1.4|5|-1.8669|-1.7092|||||||
new_0222_0554|ITOS|202012|202012|202012|339.544|336.326||1.352||21.361|14.998|6.363||323.197|-73.898||||-33.248||||3.6672|||0||1.7745|0.325|3.026|0.035||||||91.0493|35.0448|62|-0.4253|5.729|35.0448|0|35.0448|||-0.4253|0|||-38.033|||||-14.903|-14.904||33.82|33.82|848.8891|136694.9333||621878|15.5138|588.5834|6.5448|4.8164|-0.4019|0|-6.9971||-0.43|0|0|||||-1.8679||9.212|0.143||||2.617|0.542
new_0222_0554|ITOS|202101|202012|202012|||||||||||||||-30.7499||||3.4698|||0||1.6329|||||||||98.3262||||||||||||||||||||||32|32|785.1076|304380.2667||572258|14.6789|556.9092|6.1926|4.5572||||||||||1.4||||||||||
new_0222_0554|ITOS|202102|202012|202012|||||||||||||||-43.8993||||4.5086|||0||1.326|||||||||98.9742||||||||||||||||||||||41.58|41.58|1120.8368|286608.8333||464691|19.0734|723.6338|8.0464|5.9215||||||||||||||||||||
new_0222_0554|ITOS|202103|202103|202103|324.919|321.385||4.396||20.28|11.83|8.45||312.609|-87.432||||-21.4739||||3.8379|||0||3.753|1.241|5.3|0.035|||||||35.0867|68|-0.39|7.046|35.101|0|35.101|||-0.39||||-46.32|||||-13.534|-13.534||34.18|34.18|878.3672|289033.0333||1317343|15.6789|594.8486|6.625|4.8754|-0.4643|0|15.9972||-0.39|0|0|0|46.5|1.5|4|-1.9756|-2.2523|11.643|0.126||||5.594|0.641
new_0222_0554|ITOS|202104|202103|202103|||||||||||||||-12.3153||||2.6395|||0||4.935||||||||||||||35.097|||||||||||||||||23.51|23.51|503.7455|321976.8||1732037|10.7844|409.1542|4.5564|3.3531|||||||||52.25|1.5|4|||||||||
new_0222_0554|ITOS|202105|202103|202103|||||||||||||||-9.7705||||2.3065|||0||5.0469||||||||||||||35.104|||||||||||||||||20.54|20.54|399.6512|241924.7333||1771654|9.422|357.4661|3.9816|2.9301|||||||0|0|45.8|1.6|5|-2.0518|-2.7687|||||||
new_0222_0554|ITOS|202106|202106|202106|309.768|302.933||5.069||29.187|20.763|8.424||289.498|-113.891||||-12.1016||||3.1142|||0||2.3951|4.232|11.661|0.035|||||||35.12|78|-0.75|15.101|35.1481|0|35.1481|||-0.75||||-65.577|||||-26.459|-26.459||25.65|25.65|598.6158|748493.6333||841849|11.7661|446.3975|4.9783|3.6636|-0.5315|3.9062|-41.0968|-100|-0.75|0|142.7188|27.625|47.6|1.6|5|-2.2177|-2.352|14.238|0.15||||6.107|0.749
new_0222_0554|ITOS|202107|202106|202106|||||||||||||||-10.9505||||2.9175|||0||2.9479|||||||2.4135||||||||||||||||||||||||24.03|24.03|541.6758|480983.2333|29.8919|1036141|11.0229|418.204|4.6639|3.4322||||||||||||||||||||
new_0222_0554|ITOS|202108|202106|202106|||||||||||||||-14.0554||||3.448|||0||2.2139||||||5|1.5291|||||||35.2098|||||||||||||||||28.35|28.35|695.2648|187349.7333|-2.2414|779513|13.0046|493.3867|5.512|4.0564|||||||263.8126|27.625|49.2|1.6|5|3.555|-4.8125|||||||
new_0222_0554|ITOS|202109|202109|202109|914.137|899.767||4.98||550.34|542.228|8.112||372.039|-44.249||||0.0923|0.0566||91.6139|2.5587||0|0||2.2387|5.43|7.478|0.035|||3|1.1166|||37.4821|74|1.86|8.761|35.2575|0|35.2575||1.6694|1.86|0|||14.745|||104.271||72.413|69.642||27|27|52.1855|169204.1667|9.4447|789317|12.3853|469.8921|5.2567|3.8684|5.545|256.9062|-66.4563|-59.4128|1.86|104.271||||||||16.102|0.176||||5.867|1.015
new_0222_0554|ITOS|202110|202109|202109|||||||||||||||0.0767|||90.7657|2.5351|||0||2.2959||||||4|0.7493||||||||||||||||||||||||26.75|26.75|43.3711|135166.6667|23.9|809475|12.2706|465.5412|5.208|3.8326||||||||||||||||||||
new_0222_0554|ITOS|202111|202109|202109|||||||||||||||0.611|||119.7767|3.3469|||0||1.3041||||||5|-0.7627|||||||35.2739|||||||||||||||||35.3|35.3|345.4017|231671.9333|31.7656|459991|14.8067|6.9128|6.5629|3.8186|||||||189.7294|326.0816|46.6|1.6|5|2.384|5.1065|||||||
new_0222_0554|ITOS|202112|202112|202112|||||||||||||||1.3135|||157.9831|4.4145|||0||2.0264||||||7|-0.5035||||||||||||||||||||||||46.56|46.56|742.5858|344029.7667|37.67|714789|9.1178|9.3509|5.0366|10.8053|1.6585|85.4584|||||189.7294|326.0816|50.2|1.6|5|2.384|5.1065|||||||
new_0222_0554|ITOS|202201|202112|202112|||||||||||||||0.6933|||124.2556|3.472|||0||3.7525||||||8|0.6346||||||||||||||||||||||||36.62|36.62|391.9632|716644.9333|14.4375|1323644|7.1713||3.9614|8.4985|||||||326.0816|151.9958|50.2|1.6|5|5.105|-4.41|||||||
new_0222_0554|ITOS|202202|202112|202112|||||||||||||||0.5192|||114.7889|3.2075|||0|||||||||||||||||||||||||||||||||33.83|33.83|293.549|389657.4667|-13.3231||6.6249||3.6596|7.851|||||||326.0816|151.9958|50.2|1.6|5|5.1065|-4.4079|||||||
new_0222_0554|ITOS|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||1.395|76.825||||||||||||||||||
new_0222_0554|ITOS|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||1.32|76.825||||||||||||||||||
new_0222_0554|ITOS|202209|202209|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||1.24|76.825||||||||||||||||||
new_0222_0554|ITOS|202212|202212|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||1.15|77.125||||||||||||||||||